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XenopusHemoglobin synthesis by erythrocytes continues throughout a vertebrate’s lifetime. The mechanism of
mammalian heme synthesis has been studied for many years; aminolevulinate synthase 2 (ALAS2), a
heme synthetase, is associated with X-linked dominant protoporphyria in humans. Amphibian and mam-
malian blood cells differ, but little is known about amphibian embryonic hemoglobin synthesis. We
investigated the function of the Xenopus alas2 gene (Xalas2) in primitive amphibian erythrocytes and
found that it is ﬁrst expressed in primitive erythroid cells before hemoglobin alpha 3 subunit (hba3) dur-
ing primary hematopoiesis and in the posterior ventral blood islands at the tailbud stage. Xalas2 is not
expressed during secondary hematopoiesis in the dorsal lateral plate. Hemoglobin was barely detectable
by o-dianisidine staining and hba3 transcript levels decreased in Xalas2-knockdown embryos. These
results suggest that Xalas2 might be able to synthesize hemoglobin during hematopoiesis and mediate
erythrocyte differentiation by regulating hba3 expression in Xenopus laevis.
 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).1. Introduction
Vertebrate hematopoietic development generally has two
phases that are primitive and deﬁnitive. In mice, progenitors of
the primitive erythrocyte lineage arise from the mesoderm during
gastrulation in the yolk sac region, called the blood island [1,2].
Subsequently, the deﬁnitive hematopoiesis including the produc-
tion of primitive erythrocytes occurs ﬁrst in the aorta-
gonad-mesonephros, second in the placenta during embryogene-
sis, and ﬁnally in the fetal liver [3]. Primitive hematopoiesis results
in the formation of erythroblasts, megakaryocytes and macro-
phages in the yolk sac [4]. These erythrocytes have nuclei and
hemoglobin consisting of a heterotetramer of two a- and
b-subunits of globin containing heme. In this stage, the b-subunit
globin is of the fetal type, ey-globin. Enucleated erythrocytes are
produced at the deﬁnitive hematopoiesis stage in the fetal liver.
After birth, b-subunit hemoglobin of the adult type is produced
in enucleated erythrocytes in the bone marrow [3].Zebraﬁsh, Xenopus, and chicken or quail are frequently used as
models of hematopoiesis because of species-speciﬁc advantages
and features. Xenopus laevis is particularly useful for large-scale
genetic screens and functional analyses. Eggs are available year-
round and artiﬁcial fertilization is easy. In addition, there is exten-
sive knowledge of the Xenopus cleavage patterns and fate map.
Moreover, the transparent tadpole is suitable for observing blood
cells. The primitive hematopoiesis in X. laevis begins at the neurula
stage mesoderm in ventral blood islands (VBIs). The VBI is equiva-
lent to the yolk sac blood island of amniotes. It produces a primi-
tive erythroblast and is released and circulated into peripheral
blood vessels through the vitelline vein. VBIs have anterior and
posterior regions. Progenitors of the anterior VBI (aVBI) are derived
from the dorsal marginal zone and progenitors of the posterior VBI
(pVBI) are derived from the ventral marginal zone [5]. Myeloid
genes such as spiB and mpo are expressed in aVBI and erythroid
genes such as runx, lmo2, and scl (tal1) are expressed in pVBI during
the neurula stage [6,7]. During embryogenesis, the pVBI expresses
the mature erythrocyte marker, larval globin. The dorsolateral
plate (DLP) is formed in the early tailbud following gastrulation
and is the site of deﬁnitive hematopoiesis [8]. The DLP mesoderm
is located in the region from which the mesonephros anlage is gen-
erated, and produces hematopoietic stem cells.
Table 1
Primer sequence for RT-PCR.
Gene name (Fig. 2) Primer sequence
Xalas2a Fw: 50-ATCTTCACAACAAGGATGCA-30
Rv: 50-GTTATATTGGGAAAGGAGGAC-30
Xalas2b Fw: 50-GCCTGAAGAAGAAATTTCTAG-30
Rv: 50-AAAGCAGGAGGAGAAAAGAAG-30
odc Fw: 50-GTCAATGATGGAGTGTATGGATC-30
Fw: 50-TCCAATCCGCTCTCCTGAGCAC-30
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been studied in detail in mammals for many years. The heme syn-
thesis pathway is evolutionarily conserved in vertebrates, and d-
aminolevulinic acid (ALA) is prepared synthetically from succi-
nyl-CoA and glycine in the ﬁrst reaction of heme synthesis [9].
The enzymes catalyzing this reaction are aminolevulinic acid syn-
thases (ALASs). Two ALAS isozymes are encoded by ALAS-1 (also
known as nonspeciﬁc ALAS), which is nonspeciﬁcally expressed
in adult mammals, and ALAS-2 (also known as erythroid ALAS),
which is speciﬁcally expressed in erythroid cells [10]. d-ALA pro-
duction is followed by a catalytic series that leads to the formation
of heme. The catalytic series is mediated by ALA dehydratase, por-
phobilinogen deaminase, uroporphyrinogen III synthase, uropor-
phyrinogen decarboxylase, coproporphyrinogen oxidase,
protoporphyrinogen oxidase, and ferrochelatase in the mitochon-
dria and cytosol [9]. Heme regulates several biological processes
through heme-responsive or heme sensor proteins [11]. Hemoglo-
bin consists of a heterotetramer of two a- and b-subunits of globin
containing synthesized heme in a complex with divalent iron (FeII)
and porphyrin. ALAS2 is important enzyme of heme synthesis in
erythrocyte and deletion of C-terminal of ALAS2 causes X-linked
dominant protoporphyria in humans [12].
It is unclear whether ALAS have functions other than heme syn-
thesis. Amphibian blood cells differ in some ways from mamma-
lian blood cells and little is known about embryonic heme
synthesis in amphibians. We here show that Xenopus alas2 (Xalas2)
is ﬁrst expressed in primitive erythroid cells during primary hema-
topoiesis before transcription of embryonic globin and is not
detected in the DLP during secondary hematopoiesis. This is the
ﬁrst report on hemoglobin metabolism-related gene expression
in X. laevis.Table 2
Primer sequence for MO design and activities.
Name (Fig. S1) Primer sequence
Injected Xalas2a Fw: 50-CCGGATCCAGTGCAGGGCAACAGAAAC-30
Rv: 50-CCATCGATCAGAGGCATACATAGTAATGTATTTT-30
Injected Xalas2a
5misa
Fw: 50-CCGGATCCATGGCATCACTGATAAATCGATGTCCC-30
Rv: 50-CCATCGATCAGAGGCATACATAGTAATGTATTTT-30
Injected Xalas2b Fw: 50-CTTGACGTGTGAACATGGCTTCTCTCATCAATCG-30
Rv: 50-GTGTCTGTTGCCCTGCACTG-30
Injected Xalas2b
5misa
Fw: 50-CCGGATCCATGGCATCACTGATAAATCGATGTCCC-30
Rv: 50-CCATCGATCAGAGGCATACATAGTAATGTATTTT-30
a Xalas2a, b 5mis introduces ﬁve mutations into Xalas2a mRNA.2. Materials and methods
2.1. Animals
This study was conducted in accordance with the Guidelines for
Proper Conduct of Animal Experiments of the Science Council of
Japan and was approved by the National Institute of Advanced
Industrial Science and Technology as part of a project for develop-
ment of an organ-formation roadmap and application of differenti-
ation technology (No. 0000187-549).
2.2. Embryo culture and manipulation
X. laevis eggs were obtained by injecting adult frogs with 200 lL
100 U/mL Gestoron (Kyoritsu Seiyaku), then artiﬁcially fertilized,
cultured [13], and staged according to Nieuwkoop and Faber
[14]. The embryos were dejellied with 1% sodium thioglycollate
[15]. The dejellied embryos were washed several times with 10%
Steinberg’s solution, then injected with RNAs (1 ng) or morpholino
antisense oligonucleotides (MO, 40 ng) in 1  high-salt modiﬁed
Barth’s saline (MBSH)/5% Ficoll solution in the ventral or dorsal
vegetal side of the 8-cell-stage embryo. Embryos were cultured
with 10% Steinberg’s solution.
2.3. RNA extraction and reverse transcription-polymerase chain
reaction (RT-PCR)
Total RNA was extracted from embryos and adult organs by
phenol methods [15]. First-strand cDNA was synthesized from
1 lg total RNA using an oligo (dT) primer and SuperScript™ III
RT (Life Technologies) in a 50 lL reaction. The cDNA (2 lL) was
used as a template for RT-PCR. The Xenopus odc gene was used as
an internal control. Primer sequences are listed in Table 1.2.4. MO design and activities
The complete Xalas2 coding sequence was ampliﬁed by RT-PCR,
digested with BamHI and XhoI, and ligated into the pCS2 plasmid.
The plasmid was digested with NotI and in vitro-capped RNA was
synthesized by using mMESSAGE mMACHINE SP6 Kit (Life Tech-
nologies). We identiﬁed the Xalas2 50 untranslated region (UTR)
sequence by 50 rapid ampliﬁcation of cDNA ends (RACE; SMARTer™
RACE cDNA Ampliﬁcation Kit, Clontech) and Xalas2-MO was
designed in Gene Tools, LLC (https://store.gene-tools.com). MO
sequences were as follows: Xalas2a-MO, 50-ACGATTAATGAGA-
GAAGCCATGTTC-30 and Xalas2b-MO 50-CAACGATTGATGAGA-
GAAGCCATGT-30. We ampliﬁed the Xalas2 coding sequence with
the 50UTR or ﬁve point mutations in the morpholino-binding site
by RT-PCR with high-ﬁdelity DNA polymerase (Pfu, Promega) and
the primers listed in Table 2.
We synthesized two types of Xalas2 mRNA from the
pCS2-50UTR-Xalas2-5myc and pCS2-5mis-alas2-5myc constructs.
To verify the activities and speciﬁcities of the MO, we injected
these mRNAs and MOs into 2-cell-stage embryos, and then cul-
tured the embryos to stage 9 before freezing. Proteins were
extracted from the embryos and resolved by sodium dodecyl sul-
fate–polyacrylamide gel electrophoresis, transferred to polyvinyli-
dene ﬂuoride membranes with an iBlot (Life Technologies) dry
blotting system, and incubated with antibodies for SC-40 HRP,
Myc 19E10, mouse monoclonal IgG (Santa Cruz Biotechnology),
AC-40 (Sigma Aldrich), and the positive control mouse IgG (H&L)
HRP-liked antibody (Cell Signaling); antibodies were detected with
enhanced chemiluminescence (SuperSignal West Femto, Pierce),
and the protein bands were visualized using an LAS1500 Analyzer
(FujiFilm).2.5. RNA probe constructs and whole-mount in situ hybridization
The Xalas2 complete mRNA sequence clone (GenBank Accession
Number BC080015) was purchased as pCMV-SPORT6 Xalas2 from
Thermo Fisher Scientiﬁc (Open Biosystems). pCMV-SPORT6 Xalas2,
pGEM T easy hba3 (NM_001086328), pBluescript II Gata1
(NM_001085640), and pBluescript II SCL [16] were transcribed
with T3 or T7 RNA polymerase and DIG RNA Labeling Mix (Roche).
The embryos were processed for whole-mount in situ hybridization
[17]; some were embedded in parafﬁn, sectioned at 10 lm, and
stained with eosin.
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Whole-embryo staining for hemoglobin expression was per-
formed using o-dianisidine (Sigma Aldrich) histochemistry accord-
ing to previously described methods [18]. After staining, the
embryos were ﬁxed in MOPS/EGTA/magnesium sulfate/formalde-
hyde buffer (MEMFA) for 3 h and incubated in benzylbenzoate/
benzyl alcohol (BB/BA).3. Results and discussion
3.1. Isolation of Xalas2
Using 50 RACE, we identiﬁed two Xalas2 coding sequences
(Xalas2a and Xalas2b) and compared their amino acid sequences
with those of other vertebrates. It was clear that Xalas2 contains
heme regulatory motifs (CP motif) comprised of ﬁve residues,
[Arg, Lys or Asn]-Cys-Pro-[Lys or hydrophobic residue]-[Lue or
Met] (Fig. 1). Heme binds to the CP motifs of ALAS-1 pre-proteins
and of ALAS-2 in the mitochondria [19]. The processing site and
CP motif are widely conserved in vertebrates, and mitochondrial
transport of preALAS-2 is inhibited by exogenous hemin [20]. We
suggest that Xalas2 shares the same functions and regulatory sys-
tem as other vertebrates and that its activity may be regulated
by heme.
3.2. Xalas2 was expressed in hemangioblasts and erythrocytes
Xalas2a mRNA expression increased from stage 15 and was
maintained until stage 42; in contrast, Xalas2b expression began
at stage 34 (Fig. 2A). Xalas2 expression was analyzed by in situ
hybridization to characterize its relationship with erythropoiesis.Fig. 1. ALAS2 sequence alignment and identities. Alignment of Alas2 protein sequences fr
human (Accession No. NP_000023), mouse (Accession No. NP_033783), and zebraﬁsh (A
motif [Arg, Lys or Asn]-Cys-Pro-[Lys or hydrophobic residue]-[Lue or Met]). The blue b
precursor protein processing by mitochondrial peptidase.Xalas2 expression started in the anterior ventral mesoderm at the
neurula stage (Fig. 2B, C), similar to scl (Fig. 2K), which encodes a
transcription factor that regulates hematopoietic factors [21] and
acts in the early ventral mesoderm to specify hematopoietic stem
cells in X. laevis [22]. Xalas2 and scl expression patterns presented
largely the same features such as two crossing lines and pVBI in
stage 23 (Fig. 2D, D0 and L). The hba3 gene is a globin gene for alpha
hemoglobin and an erythrocyte marker in embryonic hematopoie-
sis. At stage 38, the point of vasculogenesis and blood cell circula-
tion, Xalas2 expression was observed in the aortic arch near the
heart and posterior condylar vein (Fig. 2F and F0) narrower than
hba3 (Fig. 2J); Scl expression decreased (Fig. 2N). These results sug-
gest Xalas2 is expressed in circulating erythrocytes (Fig 2F00, J00).
Other heme synthetases are present as maternally derived mRNA
[23], indicating that Xalas2 could be a rate-limiting enzyme in
Xenopus, similar to its function in mammals.3.3. Inhibition of alas2 translation also inhibited embryonic
hemoglobin synthesis
To demonstrate the role of Xalas2, we inhibited the translation
of the two alas2 types. The designed Xalas2a-MO and Xalas2b-MO
inhibited translation (Fig. S1). Hemoglobin staining with o-dianis-
idine conﬁrmed XAlas2 function as a heme synthase in the Xenopus
embryo. Hemoglobin was nearly undetectable in embryos injected
with Xalas2MOs (Fig. 3B). Succinylacetone is structurally similar to
aminolevulinic acid; therefore, it competes with aminolevulinic
acid and prevents synthesis of porphobilinogen. The amount of
hemoglobin was inversely related to succinylacetone dose
(Fig. 3C, D); addition of 0.25 mM succinylacetone abolished hemo-
globin synthesis (Fig. 3C). Thus, Xalas2 MO and succinylacetone
prevent hemoglobin synthesis in erythrocytes during tadpoleom Xenopus (type A Accession No. NP_001087499; type B Accession No. AAH84616),
ccession No. NP_571757). The yellow box indicates the heme regulatory motif (CP
ox indicates the catalytic core domain. The green arrowhead indicates the site of
Fig. 2. Xalas2 and erythrocyte-related gene expression in X. laevis embryos. (A) RT-PCR analysis of Xalas2 type a and b expression during Xenopus development. Ornithine
decarboxylase (odc) served as an internal control. Whole-mount in situ hybridization analysis using Xalas2 antisense probe (B–F, D0–F0 , E00 , F00), hba3 (G–J, I0 , J0), and scl (K–N).
(B) Stage 15: ventral view shows weak Xalas2 expression in the primitive hemangioblast (arrowhead). (C) Stage 18: expression in the primitive hemangioblast is extensive as
viewed from the ventral side. (D, D0) Stage 23, (E, E0) stage 34: ventral, lateral views of the same embryo show extensive staining in the ventral blood island (VBI; arrowmark).
(F, F0) Stage 38: expression of alas2 is extensive in the circulatory system (ventral and lateral views). Eosin-stained sections showing Xalas2 expression in stage 34 (E00) and
stage 38 (F00), and hba3 expression in the same stage (I0 , J0). Transverse sections in panels E00 , F00 , I0 , J0 of embryos are from the respective positions of the red lines in panels E0 , F0 ,
I, J. DLP, dorsal lateral plate; AA, aortic arch; PCV, posterior cardinal vein. Scale bars in stages 15, 18, and 23 indicate 0.5 mm; in stages 34 and 38, the bar represents 0.1 mm.
Fig. 3. Hemoglobin staining in Xalas2-MO injected and succinylacetone-treated embryos. The control-MO injected embryo (ventral vegetal) (A, A0). Hemoglobin staining in
Xalas2 MO-injected embryo (B, B0), succinylacetone (C, C0 , D, D0). Embryo treated with 0.25 mM succinylacetone (C, C0) and untreated embryo (D, D0) from the 8-cell-stage to
stage 42. Scale bars in (A–D) and (A0–D0) indicate 0.5 mm and 0.25 mm, respectively. Arrowheads indicate an erythrocyte stained with o-dianisidine.
A. Ogawa-Otomo et al. / Biochemical and Biophysical Research Communications 456 (2015) 476–481 479
480 A. Ogawa-Otomo et al. / Biochemical and Biophysical Research Communications 456 (2015) 476–481embryogenesis, demonstrating the conservation of function in
mammals.
3.4. Xalas2 regulated hba3 mRNA expression in VBI
The function of Xalas2 before erythrocyte generation has not
been reported elsewhere. When we injected both 8-cell blasto-
meres in the dorsal-vegetal with Xalas2a-MO and Xalas2b-MO, an
effect was observed for aVBI. In contrast, when the injection was
in the ventral-vegetal, the MOs affected pVBI. The scl expression
in aVBI in embryos injected with Xalas2MOs into the dorsal or ven-
tral regions did not differ from that of control MO-injected
embryos (Fig. 4A–E). Scl expression was hardly detected in the aor-
tic arch in Xalas2 MO-injected embryos (dorsal-vegetal injection)
at stage 34 (Fig. S2). The V-shape expression of hba3 disappeared
at stage 34 in pVBI in embryos that were injected with Xalas2Fig. 4. Erythrocyte gene expression in Xalas2-MO injected embryos. Embryos were micr
Xalas2-MO. Whole-mount in situ hybridization of scl in stage 23 (A–E), and hba3 (F–K), Ga
number of phenotypes, which a photograph present per total number of injected embryo
independently at least two times. Scale bars represent 0.5 mm.MO at the dorsal-vegetal side (Fig. 4G). There was a slight differ-
ence in the disrupted expression between control MO and Xalas2
MO-injected embryos (Fig. 4F–H, Table S1). Upon injection in the
ventral vegetal side, the expression of hba3 in pVBI disappeared
more frequently (62–82%) than in the control MO-injected embryo
(Fig. 4I–K, Table S2). In the mouse, fetal ey-globin expression is sig-
niﬁcantly reduced in E10.5 Alas-2 mutant embryos compared to
wild-type embryos [24]. Although Hba3 is an a-globin type, our
results suggest that XAlas2 also inhibits expression of hba3 in pVBI.
Thus, inhibition of Xalas2 translation did not affect primitive eryth-
rocyte marker expression at the neurula stage (Fig. 4A–E), but
hematopoietic differentiation and hba3 expression were inhibited
at the tailbud stage (Fig. 4F–K). In Xenopus primary hematogenesis,
XAlas2 inﬂuences embryonic globin gene expression. Gata1 is a
hematopoiesis-related transcription factor. The expression of gata1
at stage 34 was not affected by Xalas2-MO injection (Fig. 4L–N), butoinjected in the dorsal-vegetal side (Dor) and ventral-vegetal side (Ven) with 40 ng
ta1 (L–N), and scl (O–Q) in stage 34. The arrow indicates two crossing lines (A). The
s is indicated at the lower, left of the each ﬁgure. The experiments were performed
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Q). Thus, XAlas2 may not regulate gata1, but it does maintain scl
expression throughout the VBI. XAlas2 or the heme synthesized
by XAlas2 may not regulate hba3 through gata1 and scl; hba3
expression may be regulated by another pathway [25,26]. This is
the ﬁrst report on heme synthesis and function in Xenopus and
the mechanism by which alas2 is associated with the embryonic
globin gene remains unclear. The evolution of hematogenesis in
animals will be clariﬁed by solving the complicated mechanism
of primary hematogenesis in amphibians.
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